Madison Avenue Partners LP Invests $76.34 Million in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Madison Avenue Partners LP purchased a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 1,925,327 shares of the company's stock, valued at approximately $76,339,000. Acadia Healthcare makes up 8.1% of Madison Avenue Partners LP's portfolio, making the stock its 5th largest holding. Madison Avenue Partners LP owned 2.07% of Acadia Healthcare at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of ACHC. Lindbrook Capital LLC boosted its holdings in shares of Acadia Healthcare by 1,342.0% in the fourth quarter. Lindbrook Capital LLC now owns 721 shares of the company's stock worth $29,000 after buying an additional 671 shares during the last quarter. Blue Trust Inc. grew its holdings in shares of Acadia Healthcare by 69.4% in the fourth quarter. Blue Trust Inc. now owns 842 shares of the company's stock valued at $33,000 after purchasing an additional 345 shares in the last quarter. Nisa Investment Advisors LLC grew its holdings in shares of Acadia Healthcare by 40.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock valued at $41,000 after purchasing an additional 301 shares in the last quarter. Signaturefd LLC grew its holdings in shares of Acadia Healthcare by 460.6% in the fourth quarter. Signaturefd LLC now owns 1,222 shares of the company's stock valued at $48,000 after purchasing an additional 1,004 shares in the last quarter. Finally, Fifth Third Bancorp increased its position in Acadia Healthcare by 56.0% during the fourth quarter. Fifth Third Bancorp now owns 1,264 shares of the company's stock valued at $50,000 after acquiring an additional 454 shares during the last quarter.

Wall Street Analyst Weigh In

ACHC has been the subject of several research analyst reports. Mizuho decreased their target price on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating for the company in a research report on Wednesday, May 14th. KeyCorp reduced their target price on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. Guggenheim started coverage on shares of Acadia Healthcare in a report on Wednesday, April 9th. They set a "buy" rating and a $36.00 price objective on the stock. Bank of America cut their price target on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a report on Friday, February 28th. Finally, Royal Bank of Canada cut their price target on shares of Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating on the stock in a report on Monday, March 3rd. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $47.94.

Acadia Healthcare Trading Down 3.0%

ACHC stock traded down $0.80 during midday trading on Monday, hitting $25.36. 450,277 shares of the company's stock were exchanged, compared to its average volume of 1,702,711. Acadia Healthcare Company, Inc. has a 1-year low of $20.36 and a 1-year high of $82.41. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The business has a 50-day simple moving average of $26.19 and a two-hundred day simple moving average of $35.49. The stock has a market capitalization of $2.34 billion, a PE ratio of 8.31, a P/E/G ratio of 1.46 and a beta of 1.01.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its earnings results on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.35 by $0.05. The firm had revenue of $770.51 million during the quarter, compared to analyst estimates of $769.90 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. Acadia Healthcare's revenue was up .3% compared to the same quarter last year. During the same period last year, the business posted $0.84 earnings per share. On average, sell-side analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.